Incontinentia Pigmenti: A Comprehensive Review and Update

被引:53
作者
Swinney, Christian C. [1 ]
Han, Dennis P. [2 ]
Karth, Peter A. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst,Horngren Family Vitreoretinal Ctr, Palo Alto, CA 94303 USA
[2] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA
关键词
BLOCH-SULZBERGER-SYNDROME; CORNEAL ABNORMALITIES; NEMO; ANOMALIES; MANIFESTATIONS; RETINOPATHY; DEFICIENCY; MUTATION; NECROSIS; DISEASES;
D O I
10.3928/23258160-20150610-09
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Incontinentia pigmenti (IP) is a rare syndrome with skin lesions, ocular abnormalities in the retina and elsewhere, central nervous system abnormalities, and teeth defects. The authors present an updated review of the literature, highlighting diagnosis, epidemiology, pathophysiology, clinical features, and management of IP. IP is an X-linked dominant syndrome with an incidence of 0.0025%; most patients are female. IP is caused by a mutation in the IKBKG gene, causing a loss of function of NF-kappa beta, leaving cells susceptible to apoptosis from intrinsic factors. The cardinal feature of IP is four stages of skin distinctive lesions. Of those with IP, 36.5% have detectable eye pathology and 60% to 90% of those have retinal issues. Peripheral avascularity and macular occlusive disease commonly occur. The authors performed a comprehensive review of Medline from 1947 to 2014. All papers mentioning IP in ophthalmologic journals were reviewed as well as applicable publications from other medical specialties.
引用
收藏
页码:650 / 657
页数:8
相关论文
共 62 条
[31]   Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis [J].
Li, YG ;
Kang, J ;
Friedman, J ;
Tarassishin, L ;
Ye, JJ ;
Kovalenko, A ;
Wallach, D ;
Horwitz, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1042-1047
[32]   Prospects for Treatment of Pediatric Vitreoretinal Diseases with Vascular Endothelial Growth Factor Inhibition [J].
Lin, Kristie L. ;
Hirose, Tatsuo ;
Kroll, Arnold J. ;
Lou, Peter L. ;
Ryan, Edward A. .
SEMINARS IN OPHTHALMOLOGY, 2009, 24 (02) :70-76
[33]   Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti [J].
Makris, C ;
Godfrey, VL ;
Krähn-Senftleben, G ;
Takahashi, T ;
Roberts, JL ;
Schwarz, T ;
Feng, LL ;
Johnson, RS ;
Karin, M .
MOLECULAR CELL, 2000, 5 (06) :969-979
[34]   Incontinentia pigmenti diagnostic criteria update [J].
Minic, S. ;
Trpinac, D. ;
Obradovic, M. .
CLINICAL GENETICS, 2014, 85 (06) :536-542
[35]   Systematic review of central nervous system anomalies in incontinentia pigmenti [J].
Minic, Snezana ;
Trpinac, Dusan ;
Obradovic, Miljana .
ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
[36]   Dental and oral anomalies in incontinentia pigmenti: a systematic review [J].
Minic, Snezana ;
Trpinac, Dusan ;
Gabriel, Heinz ;
Gencik, Martin ;
Obradovic, Miljana .
CLINICAL ORAL INVESTIGATIONS, 2013, 17 (01) :1-8
[37]   Ocular Anomalies in Incontinentia Pigmenti: Literature Review and Meta-Analysis [J].
Minic, Snezana ;
Obradovic, Miljana ;
Kovacevic, Igor ;
Trpinac, Dusan .
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (7-8) :408-413
[38]   NEMO, NFκB signalling and incontinentia pigmenti [J].
Nelson, DL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (03) :282-288
[39]   Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling [J].
Nenci, A ;
Huth, M ;
Funteh, A ;
Schmidt-Supprian, M ;
Bloch, W ;
Metzger, D ;
Chambon, P ;
Rajewsky, K ;
Krieg, T ;
Haase, I ;
Pasparakis, M .
HUMAN MOLECULAR GENETICS, 2006, 15 (04) :531-542
[40]  
Nix R R, 1981, Retina, V1, P156